Thomas Jensen Profile
Thomas Jensen

@thjendk

Followers
58
Following
48
Media
1
Statuses
10

PhD fellow, Department of Cardiology, Aarhus University Hospital @AUHCardio @AarhusUni

Joined October 2021
Don't wanna be here? Send us removal request.
@SABOURETCardio
SABOURETCardiologist
3 years
What a good surprise for #Christmas ! ☀️🎄☀️ our article is online with FREE access thanks to @LeonOuazana and @CNCFCardio #SAPT #DAPT #CardioTwitter
@stecacMD
Stefano Cacciatore, MD
3 years
“De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?”, this year’s Xmas present is brought to you by @SABOURETCardio @LuigiSpadafora @MattiaGalli10 @gbiondizoccai @maciejbanach et al in @EJIM_journal
9
16
66
@thjendk
Thomas Jensen
3 years
Read our newest paper in the European Heart Journal - Cardiovascular Pharmacotherapy👇 We show that cessation of antiplatelet therapy is safe and effective beyond 1 year after PCI in patients with atrial fibrillation https://t.co/qz8VROjo5f @AgewallStefan @AUHCardio
academic.oup.com
AbstractAims. Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrilla
0
3
11
@Anders_K_H
Anders Kramer
3 years
Standardization and a common nomenclature for #yesCCT findings following #LAAO is needed for both research and training purposes! We propose a novel algorithm for interpretation of hypoattenuated thickening (HAT) on the #Watchman FLX. @AUHCardio https://t.co/CWxCEbfFLR
0
5
17
@MattiaGalli10
Mattia Galli
3 years
Real world data supporting the use of long-term OAC monotherapy (without an antiplatelet agent) beyond 1 year after PCI in patients with atrial fibrillation. #ehjcvp https://t.co/lzjh60ty8I
academic.oup.com
AbstractAims. Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrilla
0
2
5
@SABOURETCardio
SABOURETCardiologist
3 years
Antithrombotic treatment beyond one year after #PCI in patients with #AF . New data after the RCT #AFIRE
2
9
19
@thjendk
Thomas Jensen
4 years
Read our newest study in @EJCI_News!🎉 https://t.co/4xtQiLhnFf Guideline implementation of the CHA2DS2-VASC score was associated with increased use of triple therapy and a decline in ischemic outcomes. Paradoxically, risk of bleeding remained constant @AUHCardio @michael_maeng
1
3
15
@Anders_K_H
Anders Kramer
4 years
#LAAO is an attractive alternative in cases of concurrent AFib and haemophilia. Close collaboration between cardiovascular and haematological specialists can provide a safe and feasible approach! @KasperKorsholm @Nielsen_Kudsk @AUHCardio @JICE_EP https://t.co/ATD8bT3Rfm
0
5
18
@AUHCardio
Department of Cardiology Research AUH
4 years
A huge thank to @DCAcademyDK for two phenomenal days at “Empower Your Talent” course in Aarhus! The days included motivational and inspiring talks and networking with fellow #cardiovasular researchers 🫀
1
5
27
@thjendk
Thomas Jensen
4 years
Today, at the annual Research Meeting for the Institute of Clinical Medicine, we are presenting our work on long-term anticoagulatory therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. If you are at AUH, come say hi! @AUHCardio @AarhusUni
1
0
16
@TanjaCharlotteF
Tanja Charlotte Frederiksen
4 years
I had two inspiring days in great company with fellow researchers in #cardiovascular disease @DCAcademyDK Very proud to be a part of this visionary community 🌟 @DFyenbo @omeedneghabat @LNAndreasen @thjendk @AnneKaltoft @aalkjaer @etbrondum @FinnGustafsson @MortenAlbaek
0
1
14